✦ LIBER ✦

Synergism of cisplatin and mitomycin C in sensitive and resistant cell subpopulations of a tumor model

✍ Scribed by Ralph E. Durand

Publisher: John Wiley and Sons
Year: 1989
Tongue: French
Weight: 767 KB
Volume: 44
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910440528

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanism of cross-resistance to cisplat

Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line

✍ Shivendra V. Singh; Bing H. Xu; Jitesh P. Jani; Erling O. Emerson; Mary G. Backe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 730 KB

This study was undertaken to elucidate the mechanism@) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)resistant human bladder cancer cell line, J82/MMC. The J82/ MMC cell line displayed 2-to 3-fold cross-resistance to CDDP and carboplatin when compared to the parental )82/WT cells. Dr

Effect of shock waves and cisplatin on c

Effect of shock waves and cisplatin on cisplatin-sensitive and -resistant rodent tumors in vivo

✍ Norbert Weiss; Michael Delius; Stefan Gambihler; Helga Eichholtz-Wirth; Peter Di 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 775 KB

The effect of a combination of shock waves with cisplatin was examined in vivo with subcutaneously implanted amelanotic melanomas (A-Mel 3) in Syrian golden hamsters and cisplatin-sensitive or cisplatin-resistant fibrosarcoma (SSK2/0 and SSK2/R2) in C3H mice. In all 3 tumor models, 4 treatment modal

Hyperphosphorylation of replication prot

Hyperphosphorylation of replication protein A in cisplatin-resistant and -sensitive head and neck squamous cell carcinoma cell lines

✍ Karoline C. Manthey; Jason G. Glanzer; Diana D. Dimitrova; Greg G. Oakley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 3 views

## Abstract ## Background Resistance to chemotherapy is a major limitation in the treatment of head and neck squamous cell carcinomas (HNSCCs), accounting for high mortality rates in patients. Here, we investigated the role of replication protein A (RPA) in cisplatin and etoposide resistance. ##

Comparison of protein kinase C activity

Comparison of protein kinase C activity and isoform expression in cisplatin-sensitive and -resistant ovarian carcinoma cells

✍ Alakananda Basu; Kelly M. Weixel 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 514 KB

Cellular sensitivity to cis-diamminedichloroplatinum(ll) (cDDP) can be regulated by protein kinase C (PKC) signal transduction pathway. Activators of PKC were shown to enhance the sensitivity of human ovarian carcinoma 2008 cells to cDDP. We have examined whether or not the PKC signal transduction p

A phase III trial of mitomycin C alone v

A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma

✍ Michael H. Veeder; James R. Jett; John Q. Su; James A. Mailliard; John F. Foley; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

Synergistic antitumor activity of mitomy

Synergistic antitumor activity of mitomycin C and cisplatin against gastric cancer cells in vitro

✍ Yoshiro Saikawa; Tetsuro Kubota; Tsong-Hong Kuo; Suguru Kase; Toshiharu Furukawa 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

The synergistic antitumor activity of mitomycin C (MMC) and cisplatin (DDP) against the gastric cancer cell lines MKN-28 and MKN-45 was assessed in vitro using the MTT assay. The synergism of the two agents was evaluated in terms of the interaction index (1.1.). The sequence of MMC followed by DDP s